Health Care Up as Biotech Rebounds -- Health Care Roundup

Dow Jones

04-03

Health care companies rose as traders rotated back into high-risk biotech firms.

Federal drug regulators missed the deadline for making a key decision regarding a Covid-19 vaccine from Novavax, days after the Food and Drug Administration's vaccine chief was pushed out.

Novavax ticked up, but remained deep in the red for the year to date. The Federal Trade Commission's lawsuit against three large pharmacy-benefit managers over insulin prices -- Cigna's Express Scripts, UnitedHealth Group's Optum Rx and CVS Health's CVS Caremark -- is on hold after President Trump fired two of the agency's commissioners.

Planned Parenthood is closing clinics and facing more financial strains as Republican control of Washington opens new avenues for weakening the abortion provider.

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

April 02, 2025 17:26 ET (21:26 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2524444615"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2524444615\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2524444615?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-03 05:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2524444615","market":"nz","top_or_hot":-1,"title":"Health Care Up as Biotech Rebounds -- Health Care Roundup","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Health care companies rose as traders rotated back into high-risk biotech firms. \n</p>\n<p>\n  Federal drug regulators missed the deadline for making a key decision regarding a Covid-19 vaccine from Novavax, days after the Food and Drug Administration's vaccine chief was pushed out. \n</p>\n<p>\n  Novavax ticked up, but remained deep in the red for the year to date. The Federal Trade Commission's lawsuit against three large pharmacy-benefit managers over insulin prices -- Cigna's Express Scripts, UnitedHealth Group's Optum Rx and CVS Health's CVS Caremark -- is on hold after President Trump fired two of the agency's commissioners. \n</p>\n<p>\n  Planned Parenthood is closing clinics and facing more financial strains as Republican control of Washington opens new avenues for weakening the abortion provider. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Rob Curran at rob.curran@dowjones.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 02, 2025 17:26 ET (21:26 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Health Care Up as Biotech Rebounds -- Health Care Roundup</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealth Care Up as Biotech Rebounds -- Health Care Roundup\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-04-03 05:26</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Health care companies rose as traders rotated back into high-risk biotech firms. \n</p>\n<p>\n  Federal drug regulators missed the deadline for making a key decision regarding a Covid-19 vaccine from Novavax, days after the Food and Drug Administration's vaccine chief was pushed out. \n</p>\n<p>\n  Novavax ticked up, but remained deep in the red for the year to date. The Federal Trade Commission's lawsuit against three large pharmacy-benefit managers over insulin prices -- Cigna's Express Scripts, UnitedHealth Group's Optum Rx and CVS Health's CVS Caremark -- is on hold after President Trump fired two of the agency's commissioners. \n</p>\n<p>\n  Planned Parenthood is closing clinics and facing more financial strains as Republican control of Washington opens new avenues for weakening the abortion provider. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Rob Curran at rob.curran@dowjones.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 02, 2025 17:26 ET (21:26 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2524444615","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2524444615","pubTimestamp":1743629160,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Health care companies rose as traders rotated back into high-risk biotech firms.Federal drug regulators missed the deadline for making a key decision regarding a Covid-19 vaccine from Novavax, days after the Food and Drug Administration's vaccine chief was pushed out.Novavax ticked up, but remained deep in the red for the year to date. The Federal Trade Commission's lawsuit against three large pharmacy-benefit managers over insulin prices -- Cigna's Express Scripts, UnitedHealth Group's Optum Rx and CVS Health's CVS Caremark -- is on hold after President Trump fired two of the agency's commissioners.Planned Parenthood is closing clinics and facing more financial strains as Republican control of Washington opens new avenues for weakening the abortion provider.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4547":"WSB热门概念","BK4139":"生物科技","BK4588":"碎股","BK4568":"美国抗疫概念","NVAX":"诺瓦瓦克斯医药"},"translate_title":"随着生物技术反弹，医疗保健上涨——医疗保健综述","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":0.9,"US10Y.BOND":0.7,"US12M.BOND":0.7,"US2Y.BOND":0.7,"US30Y.BOND":0.7,"US3Y.BOND":0.7,"US5Y.BOND":0.7,"US6M.BOND":0.7,"US7Y.BOND":0.7},"content_text":"Health care companies rose as traders rotated back into high-risk biotech firms. \n\n\n  Federal drug regulators missed the deadline for making a key decision regarding a Covid-19 vaccine from Novavax, days after the Food and Drug Administration's vaccine chief was pushed out. \n\n\n  Novavax ticked up, but remained deep in the red for the year to date. The Federal Trade Commission's lawsuit against three large pharmacy-benefit managers over insulin prices -- Cigna's Express Scripts, UnitedHealth Group's Optum Rx and CVS Health's CVS Caremark -- is on hold after President Trump fired two of the agency's commissioners. \n\n\n  Planned Parenthood is closing clinics and facing more financial strains as Republican control of Washington opens new avenues for weakening the abortion provider. \n\n\n \n\n\n  Write to Rob Curran at rob.curran@dowjones.com \n\n\n  (END) Dow Jones Newswires\n\n\n  April 02, 2025 17:26 ET (21:26 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}